Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Carcinoma, Hepatocellular (Phase 1/Phase 2)
Digestive System Diseases (Phase 2)
Digestive System Neoplasms (Phase 2)
Endocrine Gland Neoplasms (Phase 2)
Endocrine System Diseases (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal Diseases (Phase 2)
Esophageal Neoplasms (Phase 2)
Fibrocystic Breast Disease (Phase 3)
Gastrointestinal Diseases (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Head and Neck Neoplasms (Phase 2)
Melanoma (Phase 2)
Neoplasms (Phase 2)
Pancreatic Diseases (Phase 2)
Pancreatic Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Stomach Diseases (Phase 2)
Stomach Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue